Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

NCT00571740 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was not activated

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: cetuximab
DRUG: fluorouracil
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]